These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phenytoin and IgA concentrations in plasma and saliva in epileptic children. Modéer T; Tomson G; Falk O; Rane A Acta Paediatr Scand; 1981; 70(3):373-8. PubMed ID: 7246128 [TBL] [Abstract][Full Text] [Related]
3. Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations. Anavekar SN; Saunders RH; Wardell WM; Shoulson I; Emmings FG; Cook CE; Gringeri AJ Clin Pharmacol Ther; 1978 Dec; 24(6):629-37. PubMed ID: 710022 [No Abstract] [Full Text] [Related]
5. Salivary anticonvulsant levels in children with epilepsy. Day RE; Chambers RE Br J Clin Pract; 1981 Jan; 35(1):25-9. PubMed ID: 7259942 [No Abstract] [Full Text] [Related]
6. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy. Sobaniec W Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248 [TBL] [Abstract][Full Text] [Related]
7. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Reynolds F; Ziroyanis PN; Jones NF; Smith SE Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850 [TBL] [Abstract][Full Text] [Related]
9. [Testing of the salivary gland function]. Rauch S; Khaksar A HNO; 1966 Apr; 14(4):120-1. PubMed ID: 5983808 [No Abstract] [Full Text] [Related]
10. Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy. Aman MG; Paxton JW; Field CJ; Foote SE Am J Ment Defic; 1986 May; 90(6):643-50. PubMed ID: 3717220 [TBL] [Abstract][Full Text] [Related]
12. Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations. Paxton JW; Rowell F; Ratcliffe JG; Lambie DG; Nanda R; Melville ID; Johnson RH Eur J Clin Pharmacol; 1977; 11(1):71-4. PubMed ID: 832662 [TBL] [Abstract][Full Text] [Related]
13. [Application of drug monitoring with saliva--the influence of phenytoin upon the salivary inorganic constituents]. Watanabe S; Igarashi S; Ichida T Rinsho Byori; 1986 Mar; 34(3):254-61. PubMed ID: 3712786 [No Abstract] [Full Text] [Related]
14. A new diagnostic test for pancreatic disorders by examination of parotid saliva. Kakizaki G; Saito T; Soeno T; Sasahara M; Fujiwara Y Am J Gastroenterol; 1976 May; 65(5):437-45. PubMed ID: 949352 [TBL] [Abstract][Full Text] [Related]
15. Aberrantly high phenytoin concentrations in saliva. Precaution in monitoring phenytoin concentrations in whole saliva. Paxton JW; Foote S Br J Clin Pharmacol; 1979 Nov; 8(5):508-9. PubMed ID: 508560 [No Abstract] [Full Text] [Related]
16. Comparison of phenytoin determinations in plasma, plasma dialysate and saliva for control of antiepileptic therapy in children. Brügmann G; Kleinau E; Nolte R; Petruch F Klin Wochenschr; 1979 Jan; 57(2):93-4. PubMed ID: 762949 [TBL] [Abstract][Full Text] [Related]
17. Gyrase inhibitor ciprofloxacin in human parotid saliva. Adler D; Maier H J Clin Chem Clin Biochem; 1989 Apr; 27(4):232-3. PubMed ID: 2738528 [TBL] [Abstract][Full Text] [Related]
19. [Monitoring therapy by analysis of the drug concentration of saliva]. Bartels H; Günther E; Wallis S Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213 [TBL] [Abstract][Full Text] [Related]
20. Drug formulation and salivary phenytoin measurements. Ayers GJ; Burnett D Lancet; 1977 Mar; 1(8012):656. PubMed ID: 66462 [No Abstract] [Full Text] [Related] [Next] [New Search]